REUTERS: Biogen Inc is planning to file for U.S. regulatory approval for its Alzheimer's treatment aducanumab after fresh analysis of its clinical trial showed promise, the drugmaker said on Tuesday, sending its shares up 21per cent before the bell.
Biogen and partner Eisai Co Ltd had in March decided to end two late-stage trials of the treatment based on a so-called"futility analysis" of data, which revealed the trials had little hope of succeeding.Since the Alzheimer drug's failure, Wall Street has been calling on Biogen to beef up its pipeline through deals, especially at a time when its peers are looking to sign multi-billion dollar acquisitions.
The drugmaker said on Tuesday a new analysis of the discontinued studies, which looked at a larger set of data, showed the drug was"clinically active." Based on discussions with the FDA, Biogen said it plans to submit a marketing application for aducanumab in early 2020. Shares of Biogen, which have lost 25.7per cent of its value this year through Monday close, were up at US$272.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Hot stock: SembMarine shares jump 11.6%, gets SGX querySHARES of Sembcorp Marine surged on Monday afternoon, prompting a query from the Singapore Exchange (SGX) on the stock's 'unusual price movements'. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Singapore stock index jumps 1.1% at Tuesday's open; Keppel shares soarSINGAPORE - Singapore stocks rallied more than 1 per cent on Tuesday morning (Oct 22) following a slew of major corporate developments the previous day.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
AMS posts third-quarter revenue jump, sees strong demand from Apple, othersApple supplier AMS beat expectations with a 41per cent jump in third-quarter revenue on Tuesday and forecast further strong demand for its ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Iraq says US forces withdrawing from Syria have no approval to stayBAGHDAD (REUTERS) - US forces that crossed into Iraq as part of a pull-out from Syria do not have permission to stay and can only be there in transit, the Iraqi military said on Tuesday (Oct 22).. Read more at straitstimes.com. So, they’re just barging into Iraq? Thought Iraq was a sovereign state? To DT, sovereignty may be too much to grasp.
Source: The Straits Times - 🏆 8. / 63 Read more »
Trump praises US-China trade talks as Beijing seeks billions in WTO case against USPresident Donald Trump continued to speak optimistically about the possibility of a deal to end the U.S. trade war with China, telling reporters ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
China seeks US$2.4 billion in sanctions against US in Obama-era case: WTOChina is seeking US$2.4 billion in retaliatory sanctions against the United States for non-compliance with a WTO ruling in a tariffs case dating ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »